Abstract
Aims
The aim of this study is to describe the incidence and characteristics of neovascularization in the fellow eye of patients with retinal angiomatous proliferation (RAP).
Methods
This is a retrospective study conducted on all patients with a diagnosis of unilateral RAP commencing treatment in a single centre between November 2002 and January 2010. Clinical biomicroscopic examination, fluorescein angiography, and if required, indocyanine green angiography, and optical coherence tomography were used to evaluate all patients.
Results
In all, 37 patients had a follow-up of ⩾1 year, 28 ⩾2 years, and 11 ⩾3. Patients who developed RAP in the fellow eye were: 2 of 37 (5.4%) within 1 year of follow-up, 4 of 28 (14.2%) within 2 years, and 4 of 11 (36.3%) within 3 years.
Conclusion
In our case series, the risk of neovascularization in the fellow eye of patients with unilateral RAP increased with time. Approximately one-third of patients with a 3-year follow-up developed a bilateral disease. Our findings warrant further large-scale investigation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hartnett ME, Weiter JJ, Garsd A, Jalkh AE . Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992; 230: 11–19.
Yannuzzi LA, Negrão S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416–434.
Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008; 28: 201–211.
Viola F, Massacesi A, Orzalesi N, Ratiglia R, Staurenghi G . Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009; 29: 732–739.
Borrillo JL, Sivalingam A, Martidis A, Federman JL . Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003; 121: 558–561.
Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C . Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004; 138: 1077–1079.
Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124: 487–492.
Johnson TM, Glaser BM . Focal laser ablation of retinal angiomatous proliferation. Retina 2006; 26: 765–772.
Lai TY, Chan WM, Liu DT, Lam DS . Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1877–1880.
Gross NE, Aizman A, Brucker A, Klancnik Jr JM, Yannuzzi LA . Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 2005; 25: 713–718.
Gass JD, Agarwal A, Lavina AM, Tawansy KA . Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003; 23: 741–751.
Monson DM, Smith JR, Klein ML, Wilson DJ . Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 2008; 126: 1664–1668.
Yannuzzi LA, Freund KB, Takahashi BS . Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 2008; 28: 375–384.
Barbazetto IA, Kumar K, Karamchandani H, Rabinowitz D, Takahashi B, Yannuzzi LA . Risk for choroidal neovascularization in the fellow eye of patients on anti-vegf therapy for neovascular age-related macular degeneration invest. Ophthalmol Vis Sci 2008; 49: 2227. E Abstract 256.
Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I et al. The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica 2009; 223 (6): 383–389.
Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993; 111: 1189–1199.
Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115: 741–747.
Acknowledgements
We thank David Parry and John Deane from the Liverpool Reading Centre for their valuable contribution in the analysis of angiograms.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
This paper has been partially presented as a poster at the ARVO 2009 meeting
Rights and permissions
About this article
Cite this article
Campa, C., Harding, S., Pearce, I. et al. Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Eye 24, 1585–1589 (2010). https://doi.org/10.1038/eye.2010.88
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2010.88
Keywords
This article is cited by
-
Functional and structural characteristics in patients with type 3 macular neovascularisation treated with anti-VEGF. Three-year results in real world settings
Eye (2024)
-
Optical Coherence Tomography Angiography: A 2023 Focused Update on Age-Related Macular Degeneration
Ophthalmology and Therapy (2024)
-
Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
Eye (2023)
